![Naseem Zojwalla](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Naseem Zojwalla
Technik-/Wissenschafts-/F&E-Leiter bei
OLEMA PHARMACEUTICALS, INC.
Vermögen: 59 197 $ am 31.05.2026
Profil
Naseem Zojwalla currently works at Olema Pharmaceuticals, Inc., as Chief Medical Officer from 2022.
Dr. Zojwalla also formerly worked at Peloton Therapeutics, Inc., as Vice President-Clinical Development from 2015 to 2020, Turning Point Therapeutics, Inc., as Vice President-Clinical Development from 2020 to 2022, and Columbia University Irving Medical Center, as Assistant Clinical Professor-Medicine.
Dr. Zojwalla received her undergraduate degree from Stanford University and doctorate degree from Temple University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.02.2026 | 4’488 ( 0.01% ) | 59 197 $ | 31.05.2026 |
Aktive Positionen von Naseem Zojwalla
| Unternehmen | Position | Beginn |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.01.2022 |
Ehemalige bekannte Positionen von Naseem Zojwalla
| Unternehmen | Position | Ende |
|---|---|---|
| TURG POIN | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
| PELOTON THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
Columbia University Medical Center
 Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Naseem Zojwalla
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University Medical Center
Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University School of Medicine
 Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
